Published in Annu Rev Clin Psychol on January 01, 2010
Medications development to treat alcohol dependence: a vision for the next decade. Addict Biol (2012) 1.56
Identifying neurobiological phenotypes associated with alcohol use disorder severity. Neuropsychopharmacology (2011) 1.41
Health behavior change: can genomics improve behavioral adherence? Am J Public Health (2012) 1.20
How psychosocial alcohol interventions work: a preliminary look at what FMRI can tell us. Alcohol Clin Exp Res (2011) 1.05
The Big Picture of Individual Differences in Physical Activity Behavior Change: A Transdisciplinary Approach. Psychol Sport Exerc (2011) 1.01
Frontal white matter integrity predictors of adult alcohol treatment outcome. Biol Psychiatry (2011) 0.97
The contributions of cognitive neuroscience and neuroimaging to understanding mechanisms of behavior change in addiction. Psychol Addict Behav (2013) 0.96
Proposed model of the neurobiological mechanisms underlying psychosocial alcohol interventions: the example of motivational interviewing. J Stud Alcohol Drugs (2011) 0.95
Neuroimaging mechanisms of change in psychotherapy for addictive behaviors: emerging translational approaches that bridge biology and behavior. Psychol Addict Behav (2013) 0.90
Functional connectivity and cannabis use in high-risk adolescents. Am J Drug Alcohol Abuse (2013) 0.89
Working memory as a moderator of impulsivity and alcohol involvement: testing the cognitive-motivational theory of alcohol use with prospective and working memory updating data. Addict Behav (2014) 0.88
Adolescent brain development, substance use, and psychotherapeutic change. Psychol Addict Behav (2012) 0.88
Effect of homozygous deletions at 22q13.1 on alcohol dependence severity and cue-elicited BOLD response in the precuneus. Addict Biol (2011) 0.86
Preliminary evidence for associations of CHRM2 with substance use and disinhibition in adolescence. J Abnorm Child Psychol (2011) 0.83
Brain-based origins of change language: a beginning. Addict Behav (2014) 0.83
Preliminary functional MRI results from a combined stop-signal alcohol-cue task. J Stud Alcohol Drugs (2014) 0.81
Impulsivity, variation in the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes, and marijuana-related problems. J Stud Alcohol Drugs (2013) 0.80
Perceptions of genetic testing and genomic medicine among drug users. Int J Drug Policy (2014) 0.80
Are bottom-up and top-down traits in dual-systems models of risky behavior genetically distinct? Behav Genet (2013) 0.79
Pharmacogenetic approaches in the treatment of alcohol use disorders: addressing clinical utility and implementation thresholds. Addict Sci Clin Pract (2014) 0.79
Brain proton magnetic resonance spectroscopy of alcohol use disorders. Handb Clin Neurol (2014) 0.79
White matter integrity is associated with alcohol cue reactivity in heavy drinkers. Brain Behav (2013) 0.77
Evaluating the Hispanic Paradox in the Context of Adolescent Risky Sexual Behavior: The Role of Parent Monitoring. J Pediatr Psychol (2015) 0.76
Brain regions affected by impaired control modulate responses to alcohol and smoking cues. J Stud Alcohol Drugs (2014) 0.76
Dose specific effects of olanzapine in the treatment of alcohol dependence. Psychopharmacology (Berl) (2014) 0.75
Brief report: cognitive control helps explain comorbidity between alcohol use disorder and internalizing disorders. J Stud Alcohol Drugs (2015) 0.75
Personalizing substance use treatment based on pre-treatment impulsivity and sensation seeking: A review. Drug Alcohol Depend (2016) 0.75
Maximizing Effectiveness Trials in PTSD and SUD Through Secondary Analysis: Benefits and Limitations Using the National Institute on Drug Abuse Clinical Trials Network "Women and Trauma" Study as a Case Example. J Subst Abuse Treat (2015) 0.75